Full Press Release Details
aflibercept 8 mg two year results from pivotal photon trial in diabetic macular edema presented at asrs.
REGN
aflibercept 8 mg two year results from pivotal photon trial in diabetic macular edema presented at asrs
Key Takeaway: aflibercept 8 mg two year results from pivotal photon trial in diabetic macular edema presented at asrs